Nalaganje...

Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment

INTRODUCTION: The mineralocorticoid receptor (MR) blocker esaxerenone is a new treatment for hypertension in Japan and under development for treatment of diabetic nephropathy. Hepatic impairment is known to impact the pharmacokinetics (PKs) of other MR blocking drugs. The aim of the present study wa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Adv Ther
Main Authors: Kurata, Akifumi, Yoshida, Takafumi, Inoue, Megumi, Ishizuka, Tomoko, Nakatsu, Takafumi, Shimizu, Takako, Kato, Manabu, Nishikawa, Yasuhiro, Ishizuka, Hitoshi
Format: Artigo
Jezik:Inglês
Izdano: Springer Healthcare 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6979450/
https://ncbi.nlm.nih.gov/pubmed/31705436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-01121-2
Oznake: Označite
Brez oznak, prvi označite!